1. Afatinib plus bevacizumab combination after acquired resistance to EGFR tyrosine kinase inhibitors in EGFR‐mutant non–small cell lung cancer: Multicenter, single‐arm, phase 2 trial (ABC Study). Issue 19 (7th September 2018) Authors: Hata, Akito; Katakami, Nobuyuki; Kaji, Reiko; Yokoyama, Toshihide; Kaneda, Toshihiko; Tamiya, Motohiro; Inoue, Takako; Kimura, Hiromi; Yano, Yukihiro; Tamura, Daisuke; Morita, Satoshi; Negoro, Shunichi; the HANSHIN Oncology Group, for Journal: Cancer Issue: Volume 124:Issue 19(2018) Page Start: 3830 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Alternating therapy with osimertinib and afatinib for treatment-naive patients with EGFR-mutated advanced non-small cell lung cancer: A single-group, open-label phase 2 trial (WJOG10818L). (June 2022) Authors: Hayashi, Hidetoshi; Yonesaka, Kimio; Nakamura, Atsushi; Fujimoto, Daichi; Azuma, Koichi; Sakata, Shinya; Tachihara, Motoko; Ikeda, Satoshi; Yokoyama, Toshihide; Hataji, Osamu; Yano, Yukihiro; Hirano, Katsuya; Daga, Haruko; Okada, Hideaki; Chiba, Yasutaka; Sakai, Kazuko; Nishio, Kazuto; Yamamoto, ... Journal: Lung cancer Issue: Volume 168(2022) Page Start: 38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Bronchial ethanol injection therapy for airway obstruction in lung cancer patients. Issue 9 (29th July 2021) Authors: Okabe, Fukuko; Yano, Yukihiro; Kuge, Tomoki; Uenami, Takeshi; Kanazu, Masaki; Mori, Masahide Journal: Respirology case reports Issue: Volume 9:Issue 9(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Case series of pleomorphic carcinomas of the lung treated with nivolumab. Issue 6 (7th September 2017) Authors: Kanazu, Masaki; Uenami, Takeshi; Yano, Yukihiro; Nakatsubo, Saeko; Hosono, Yuki; Ishijima, Mikako; Akazawa, Yuki; Yamaguchi, Toshihiko; Urasaki, Koji; Mori, Masahide; Yokota, Soichiro Journal: Thoracic cancer Issue: Volume 8:Issue 6(2017) Page Start: 724 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Continued administration of pembrolizumab for adenocarcinoma of the lung after the onset of fulminant type 1 diabetes mellitus as an immune‐related adverse effect: A case report. Issue 5 (9th April 2019) Authors: Edahiro, Ryuya; Ishijima, Mikako; Kurebe, Hiroyuki; Nishida, Kohei; Uenami, Takeshi; Kanazu, Masaki; Akazawa, Yuki; Yano, Yukihiro; Mori, Masahide Journal: Thoracic cancer Issue: Volume 10:Issue 5(2019) Page Start: 1276 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. EGFR‐mutant lung adenocarcinoma associated with antisynthetase syndrome successfully treated with osimertinib. Issue 9 (7th March 2021) Authors: Hara, Reina; Kanazu, Masaki; Iwai, Ami; Kuge, Tomoki; Ishijima, Mikako; Uenami, Takeshi; Akazawa, Yuki; Yano, Yukihiro; Yamaguchi, Toshihiko; Mori, Masahide Journal: Thoracic cancer Issue: Volume 12:Issue 9(2021) Page Start: 1441 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Expectoration of tonsillar metastasis of pulmonary pleomorphic carcinoma after pseudoprogression: A case report. Issue 12 (11th May 2021) Authors: Kuge, Tomoki; Okabe, Fukuko; Yamamoto, Yuji; Ishijima, Mikako; Uenami, Takeshi; Kanazu, Masaki; Akazawa, Yuki; Yano, Yukihiro; Yamaguchi, Toshihiko; Mori, Masahide Journal: Thoracic cancer Issue: Volume 12:Issue 12(2021) Page Start: 1935 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Febrile neutropenia with bacterial paronychia. Issue 3 (26th January 2018) Authors: Hosono, Yuki; Uenami, Takeshi; Yano, Yukihiro; Mori, Masahide Journal: Clinical case reports Issue: Volume 6:Issue 3(2018) Page Start: 543 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Hyperprogressive disease in patients with non‐small cell lung cancer treated with nivolumab: A case series. Issue 12 (17th October 2018) Authors: Kanazu, Masaki; Edahiro, Ryuya; Krebe, Hiroyuki; Nishida, Kohei; Ishijima, Mikako; Uenami, Takeshi; Akazawa, Yuki; Yano, Yukihiro; Yamaguchi, Toshihiko; Mori, Masahide Journal: Thoracic cancer Issue: Volume 9:Issue 12(2018) Page Start: 1782 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Monitoring antibody binding to T cells in a pembrolizumab‐treated patient with lung adenocarcinoma on hemodialysis. Issue 11 (14th September 2019) Authors: Osa, Akio; Uenami, Takeshi; Naito, Yujiro; Hirata, Haruhiko; Koyama, Shohei; Takimoto, Takayuki; Shiroyama, Takayuki; Futami, Shinji; Nakatsubo, Saeko; Sawa, Nobuhiko; Yano, Yukihiro; Nagatomo, Izumi; Takeda, Yoshito; Mori, Masahide; Kida, Hiroshi; Kumanogoh, Atsushi Journal: Thoracic cancer Issue: Volume 10:Issue 11(2019) Page Start: 2183 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗